Posted in Clinical Data Lilly’s new obesity pill passes heart safety test in diabetes April 16, 2026 BioPharma Dive The findings, which come amid FDA scrutiny of Foundayo s safety, will enable Lilly to seek a new clearance in diabetes. Clinical DataMetabolic & GLP-1Read full story